Tag : tumors

Pharma / Biotech

Phase I study of Imalumab (BAX69), a Fully Human Recombinant Anti-oxidized Macrophage Migration Inhibitory Factor Antibody in Advanced Solid Tumors.

Newsemia
Related Articles Phase I study of Imalumab (BAX69), a Fully Human Recombinant Anti-oxidized Macrophage Migration Inhibitory Factor Antibody in Advanced Solid Tumors. Br J Clin...
Gastroenterology

Direct endoscopic full-thickness resection for submucosal tumors with an intraluminal growth pattern originating from the muscularis propria layer in the gastric fundus

Newsemia
Endoscopic full-thickness resection (EFTR) is difficult to perform in a retroflexed fashion in the gastric fundus. The present study aims at exploring whether direct EFTR...
Latest News

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors

Newsemia
Plenker, D; Riedel, M; Braegelmann, J; Dammert, MA; Chauhan, R; Knowles, PP; Lorenz, C; … Sos, ML; + view all Plenker, D; Riedel, M; Braegelmann,...
AI/ML

Counting Mitoses With Digital Pathology in Breast Phyllodes Tumors.

Newsemia
Related Articles Counting Mitoses With Digital Pathology in Breast Phyllodes Tumors. Arch Pathol Lab Med. 2020 Mar 09;: Authors: Chow ZL, Thike AA, Li HH,...
Gastroenterology

Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies

Newsemia
The heterogeneity among colorectal tumors is probably due to differences in developmental pathways and might associate with patient survival times. We studied the relationship among...
Pediatrics

Combination drug therapy for childhood brain tumors shows promise in laboratory models

Newsemia
In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug...
Latest News

Granzyme B Functionalized Nanoparticles Targeting Membrane Hsp70‐Positive Tumors for Multimodal Cancer Theranostics

Newsemia
Shevtsov, M; Stangl, S; Nikolaev, B; Yakovleva, L; Marchenko, Y; Tagaeva, R; Sievert, W; … Multhoff, G; + view all Shevtsov, M; Stangl, S; Nikolaev,...
Latest News

KSQ Therapeutics Announces Discovery of Gene Targets with Potential Activity Superior to PD-1 for Development of Engineered Tumor Infiltrating Lymphocyte (eTIL™) Therapies for Solid Tumors

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the whole genome to identify optimal gene targets for...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy